Ref (type)	Population	Outcome, Interventions	Results and statistical analysis	Effect size	Favours
Sustained virological response
Systematic review	710 people with HCV (any genotype) and HIV 2 RCTs in this analysis	Proportion of people achieving a sustained virological response (SVR) with peginterferon plus ribavirin with peginterferon alone Absolute results not reported	OR 2.65 95% CI 1.87 to 3.76 P <0.0001 One RCT identified by the review was reported as only an abstract	Moderate effect size	peginterferon plus ribavirin
Systematic review	People with HCV genotype 1 or 4 and HIV: number of people in analysis not reported 2 RCTs in this analysis	Proportion of people achieving a sustained virological response (SVR) with peginterferon plus ribavirin with peginterferon alone Absolute results not reported	OR 2.46 95% CI 1.50 to 4.01 P = 0.0003 One RCT identified by the review was reported as only an abstract	Moderate effect size	peginterferon plus ribavirin
Systematic review	People with HCV genotype 2 or 3 and HIV: number of people in analysis not reported 2 RCTs in this analysis	Proportion of people achieving a sustained virological response (SVR) with peginterferon plus ribavirin with peginterferon alone Absolute results not reported	OR 3.23 95% CI 1.86 to 5.59 P <0.0001 One RCT identified by the review was reported as only an abstract	Moderate effect size	peginterferon plus ribavirin